Back to search

Combined-modality therapy for limited-stage small cell lung cancer

Data up to Jan 2025

Published2001
Citations20
References58

Total Citations Per Year

Abstract

References (58)

Manual for Staging of Cancer

1992 • 2,367 citations

Prophylactic Cranial Irradiation for Patients with Small-Cell Lung Cancer in Complete Remission

1999 • 1,607 citations

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

1999 • 1,394 citations

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

1992 • 1,295 citations

Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis.

1992 • 802 citations

Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.

1993 • 716 citations

Phase III Study of Concurrent Versus Sequential Thoracic Radiotherapy in Combination With Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Results of the Japan Clinical Oncology Group Study 9104

2002 • 671 citations

Prophylactic Cranial Irradiation for Patients With Small-Cell Lung Cancer in Complete Remission

1995 • 513 citations

Chemotherapy with or without Radiation Therapy in Limited Small-Cell Carcinoma of the Lung

1987 • 484 citations

Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

1997 • 474 citations

Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung Cancer

1991 • 444 citations

CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.

1992 • 443 citations

Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial

1997 • 363 citations

Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in limited small-cell lung cancer: a randomized study.

1997 • 339 citations

Intensive chemotherapy of small cell bronchogenic carcinoma.

1977 • 253 citations

Initial Chemotherapeutic Doses and Survival in Patients with Limited Small-Cell Lung Cancer

1993 • 249 citations

Chemotherapy Alone or Chemotherapy with Chest Radiation Therapy in Limited Stage Small Cell Lung Cancer

1987 • 225 citations

Phase III Comparison of Twice-Daily Split-Course Irradiation Versus Once-Daily Irradiation for Patients With Limited Stage Small-Cell Lung Carcinoma

1999 • 203 citations

Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.

1998 • 195 citations

Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.

1990 • 195 citations

Neurologic, neuropsychologic, and computed cranial tomography scan abnormalities in 2- to 10-year survivors of small-cell lung cancer.

1985 • 194 citations

Weekly gemcitabine with monthly cisplatin: effective chemotherapy for advanced non-small-cell lung cancer.

1997 • 185 citations

Phase II study of paclitaxel in patients with extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group study.

1995 • 178 citations

Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer. Aarhus Lung Cancer Group.

1997 • 174 citations

Prophylaxis and treatment of leukemia in the central nervous system and other sanctuaries.

1985 • 163 citations

Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study.

1995 • 157 citations

cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung.

1979 • 153 citations

Radiotherapy in small cell cancer of the lung treated with combination chemotherapy: a controlled trial.

1984 • 140 citations

Activity of docetaxel (Taxotere) in small cell lung cancer

1994 • 130 citations

The superiority of combination chemotherapy over single agent chemotherapy in small cell lung carcinoma

1979 • 111 citations

Limited-stage small-cell lung cancer: patterns of intrathoracic recurrence and the implications for thoracic radiotherapy.

1994 • 109 citations

The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a Southwest Oncology group study

1982 • 106 citations

Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: An update

1989 • 96 citations

The effect of dose of thoracic irradiation on recurrence in patients with limited stage small cell lung cancer. Initial results of a canadian multicenter randomized trial

1988 • 90 citations

Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

1997 • 89 citations

Thoracic and elective brain irradiation with concomitant or delayed multiagent chemotherapy in the treatment of localized small cell carcinoma of the lung: A randomized prospective study by the southeastern cancer study group

1981 • 80 citations

A randomized phase III study of irinotecan and cisplatin (CP) versus etoposide and cisplatin (EP) in extensive-disease small-cell lung cancer (ED-SCLC): Japan Clinical Oncology Group Study (JCOG 9511)

2000 • 73 citations

Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung.

1976 • 72 citations

Oral Etoposide and Carboplatin

1995 • 68 citations

Alternating chemotherapy and twice-daily thoracic radiotherapy in limited-stage small-cell lung cancer: a pilot study of the Eastern Cooperative Oncology Group.

1993 • 66 citations

Improved local control of thoracic disease in small cell lung cancer with higher dose thoracic irradiation and cyclic chemotherapy rose

1987 • 48 citations

Evaluation and radiotherapy implications of chest relapse patterns in small cell lung carcinoma treated with radiotherapy-chemotherapy: Study of 34 cases and review of the literature

1980 • 46 citations

Late consolidative radiation therapy in the treatment of limited-stage small cell lung cancer

1991 • 36 citations

Increased survival with high-dose multifield radiotherapy and intensive chemotherapy in limited small cell carcinoma of the lung

1985 • 35 citations

The role of consolidation irradiation in combined modality therapy of small cell carcinoma of the lung

1982 • 29 citations

A Randomized Trial of Delayed Thoracic Radiotherapy in Complete Responder Patients With Small-Cell Lung Cancer

1993 • 27 citations

Treatment of small cell lung cancer: the state of the art

1997 • 27 citations

Local Failure in Patients Treated with Radiotherapy and Multidrug Chemotherapy for Small Cell Lung Cancer

1990 • 22 citations

In: A Gregor, A Cull, RJ Stephens, JA Kirkpatrick, JR Yarnold, DJ Girling, FR Macbeth, R Stout and D Machin, Editors, Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomized trial, Eur J Cancer 33 (1997), pp. 1752–1758.

1998 • 22 citations

Prophylactic cranial irradiation in small-cell lung cancer: is it ever indicated?

1998 • 19 citations

Interdigitating versus concurrent chemotherapy and radiotherapy for limited small cell lung cancer

1995 • 17 citations

The relationship of infield recurrences to prescribed tumor dose in small cell carcinoma of the lung

1981 • 17 citations

Small cell lung cancer: The influence of dose and treatment volume on outcome

1995 • 17 citations

Phase 1 study to determine the maximum tolerated dose of radiation in standard fractionated and accelerated twice daily radiation schedules with concurrent chemotherapy for limited stage small cell lung cancer (CALGB 8837)

1994 • 15 citations

Limited Small-Cell Lung Cancer

1991 • 11 citations

Paclitaxel, carboplatin, and extended-schedule oral etoposide for small-cell lung cancer.

1998 • 8 citations

Concurrent twice-daily radiotherapy (XRT) — platinum (DDP) - etoposide (VP-16) for limited small cell lung cancer (SCLC): Update 1987

1987 • 7 citations

Small-cell lung cancer: is there a standard therapy?

1998 • 7 citations

Cited By (0)

Loading...
Combined-modality therapy for limited-stage small cell lung cancer (2001) – Seminars in Oncology | Metascience Observatory Explorer